Moreover, an increase of ICAM-1 was observed to protect neurons from Aβ neurotoxicity in both in vivo and in vitro models and can improve cognitive deficit in Aβ-infused rat and 5xFAD mouse, further suggesting a potential protective role of ICAM-1 in early-stage AD pathology defence mechanism. This evidence concerns the gene ICAM1 and Alzheimer disease.